Company Overview
Cryosite is an Australian ASX listed company established in 1999, listed in 2002. Uniquely placed in the Australian market, we established Australia’s first private Bio Repository in 2000, and in the same year opened our first Clinical Trials Depot.

Cryosite is a highly experienced and trusted depot partner in Ph. II, III & IV clinical trial logistics. We partner with clients across the globe including: pharmaceutical sponsors and manufacturers, CROs and CMOs, research institutes and biotechnology industries. Our specialised Bio Repository is a leader in secure local storage of Clinical Trial Samples and Clinical Tissue Specimens generated at Australian Clinical Trial sites.

Our facility meets the highest standards and regulations including Australian Therapeutic Goods Administration (TGA) for GMP manufacturing, NATA (ISO 15189 Medical testing), Australian Department of Agriculture (import and storage of Biological Goods subject to Quarantine), and the Pharmaceutical Regulatory Unit of the NSW Ministry of Health (Supply by Wholesale poisons and/or restricted substances for Therapeutic Use, and Supply Drugs of Addiction). With our experience, we are regarded as experts in import permits and licencing, and we perform services in this area. We can also source comparator material for your study.

Our Scientific team has expertise in Stem Cell manufacturing, cultivation and cryopreservation, storage and handling of GMO (OTGR), Human Plasma and Serum Samples, Veterinary Samples, and storage of Master and Working Cell Banks.

Cryosite leads the market in providing tailored eco-friendly reusable packaging solutions, including Credo™ 15-25°C, 2-8°C, -20°C and -50°C, Chart® MVE CryoShipper QWick™ & Vapor Series, as well as single use packaging from Peli® such as Sherpa Systems™. From our secure site in Sydney we ship to Asia Pacific, Europe and US sites as well as providing return logistics from Australian and New Zealand clinical sites.

2:30 PM–3:00 PM Jun 7, 2018 (US - Eastern)